GL1X · GenesisL1 explorer

Research workbench

Human angiopoietin-like 4 C-terminal domain (CANGPTL4) with myristic acid

Analyse Human angiopoietin-like 4 C-terminal domain (CANGPTL4) with myristic acid in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6U73
Type
protein
Length
216 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Angiopoietin-related protein 4
UniProt
Q9BY76
Ligands
MYR
Pockets
1 · best druggability 0.69

Structure

x-ray diffraction · 1 distinct chain · 19% helix, 32% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AAngiopoietin-related protein 4protein21619% helix, 32% strandQ9BY76

Ligands and binding sites

  • MYR · Myristic acid · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11490.690.8821MYR

Modifications

Observed in the structure: 2 disulfide (disulfide).

Compared structures

  • 6U73 · Human Angiopoietin-Like 4 C-Terminal Domain (cANGPTL4) with Myristic Acid · the same entry in another collection · chain A against A, TM-score 1.00
  • Q9BY76 · AlphaFold monomer V2.0 prediction for angiopoietin-related protein 4 (Q9BY76) · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.